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Abstract 22 
Given that many brain disorders are characterized by mitochondrial dysfunction, there is a growing 23 
interest in investigating genetic and epigenetic variation in mitochondrial DNA (mtDNA). One major 24 
caveat for such studies is the presence of nuclear-mitochondrial pseudogenes (NUMTs), which are 25 
regions of the mitochondrial genome that have been inserted into the nuclear genome over evolution 26 
and, if not accounted for, can confound genetic studies of mtDNA. Here we show the first systematic 27 
study to compare methods for isolating mtDNA from frozen post-mortem human brain tissue, and 28 
show that a commercial method from Miltenyi Biotech, which magnetically isolates mitochondria 29 
using antibodies raised against TOM22, gives a significant enrichment of mtDNA, and should be 30 
considered the method of choice for mtDNA studies in frozen brain tissue. 31 
 32 
 33 
 34 
 35 
 36 
Method Summary 37 
Here we compare five methods of isolating mitochondrial DNA (mtDNA) to standard phenol-38 
chloroform DNA extraction (that isolates nuclear DNA (ncDNA) and mtDNA) to determine the 39 
optimal method for enriching mtDNA from frozen post-mortem human brain tissue. 40 
 41 
 42 
 43 
 44 
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Main Text 45 
Mitochondria generate ATP, regulate calcium homeostasis [1, 2], mediate apoptosis [3], and produce 46 
reactive oxygen species (ROS). Mitochondrial dysfunction has been implicated in a number of 47 
diseases, including in the pathogenesis of brain disorders such as Alzheimer’s disease [4-6]. 48 
Mitochondria are unique mammalian organelles in that they contain their own genome; the 49 
mitochondrial genome is ~16.6kb of circular DNA (mtDNA) [7], separate to the nuclear genome 50 
(ncDNA) and inherited in a maternal, non-Mendelian fashion. The mitochondrial genome comprises 51 
37 genes; 13 encode for electron transport chain polypeptides, two for rRNAs and 22 for tRNAs. 52 
Because of its role in ROS production, mtDNA has a higher mutation rate (10-17 fold) than ncDNA 53 
[8]. Mutations in mtDNA are relatively common, with at least one in 200 healthy humans harboring a 54 
potentially pathogenic mtDNA mutation [9]. Indeed more than 300 point mutations in mtDNA are 55 
associated with disease risk and pathology in MitoMAP [10]. Interestingly, as each mitochondrion 56 
contains 2-10 copies of mtDNA and there are multiple mitochondria in any given cell, somatic 57 
mutations result in a mosaic of different mtDNA sequences within a given tissue. This phenomenon is 58 
known as mitochondrial heteroplasmy and is linked to various mitochondrial diseases [11]. Such 59 
heterogeneity is a potential confounder in studies of mitochondrial diseases, because inter- and intra-60 
individual heteroplasmic variation can confuse the association between a haplogroup and its 61 
corresponding phenotype. Therefore, unlike studies of ncDNA variation, it is important to use the 62 
specific tissue of interest for etiological research. Another interesting feature of the mitochondria is 63 
that over evolution sequences of mtDNA have translocated to the nuclear genome. Traditional 64 
mitochondrial genetic research, and more recently studies of mitochondrial epigenetics, can be 65 
hampered by the presence of these nuclear-mitochondrial pseudogenes (NUMTs) as they share a high 66 
homology with their mitochondrial paralogs [12, 13]. Given the interest in studying mtDNA genetic 67 
and epigenetic changes in the pathology of brain diseases characterized by mitochondrial dysfunction, 68 
it is imperative that NUMTs are correctly accounted for [14]. 69 
The specific isolation of mitochondria prior to downstream processing is vital to fully exclude issues 70 
relating to NUMT contamination. For this purpose, a number of methods have been developed to 71 
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specifically isolate mtDNA, although few of these approaches have been specifically optimized for 72 
use on post-mortem tissue, a major resource in many epidemiological studies. In fact most studies 73 
investigating mtDNA use fresh animal tissue or cell lines. The insult of freezing tissue prior to 74 
isolation will potentially alter the effectiveness of these techniques and increase the risk of NUMT 75 
inclusion in downstream analysis. In this study we compared the effectiveness of five different 76 
mitochondrial isolation methods on post-mortem brain tissue using quantitative real-time PCR (qRT-77 
PCR), to determine the optimal method for the specific enrichment of mtDNA, which was 78 
subsequently validated by next generation sequencing (NGS). We tested protocols based on A) 79 
Percoll gradients, B) linear DNA digestion, C) differential centrifugation, D) rapid differential 80 
centrifugation using a commercial kit and E) magnetic isolation of mitochondria using anti-TOM22 81 
antibodies.  82 
Method A was a modification of the method by Sims and Anderson (3). 150mg of tissue was 83 
dissociated using the gentleMACS dissociator (Miltenyi Biotech:130-093-235) and a mitochondrial 84 
extraction kit (Miltenyi Biotech:130-097-340). After removal of the nuclear fraction, the supernatant 85 
was spun at 13,000xg for 30 minutes at 4°C to form a crude mitochondrial pellet. The pellet was 86 
homogenized in a 12% Percoll solution and added above two layers (26% and 40%) of Percoll 87 
solution. Samples were spun at 30,700xg for 5 minutes at 4°C with the lower band containing the 88 
enriched mitochondrial fraction. Each mitochondrial fraction was diluted in four volumes of isolation 89 
buffer and centrifuged at 16,700xg for 10 minutes at 4°C to form a loose mitochondrial fraction. The 90 
supernatant was discarded, and mtDNA extracted using a DNA Mini kit (Qiagen:51304). Method B 91 
was based on the method by Zhou et al [15] that digests linear DNA but leaves circular DNA intact. 92 
20ug genomic DNA (previously extracted using a phenol-chloroform protocol) was treated with 4μl 93 
lambda exonuclease (5 U/μl) (New England Biolabs:M0262S) and 12μl RecJf (30 U/μl) (New 94 
England Biolabs:M0264S) in 400μl 1x lambda exonuclease buffer (New England Biolabs:B0262S) at 95 
37
o
C for 16 hours. Samples were incubated at 65
o
C for 10 minutes to inactivate the enzymes and 96 
subsequently purified using a DNA Mini Kit (Qiagen:51304). Method C was based on the method by 97 
Clayton and Shadel [16]. 100mg brain tissue was homogenized in 1ml chilled homogenization buffer 98 
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(0.25M sucrose/10mM EDTA/30mM Tris-HCl, pH 7.5). The homogenate was centrifuged at 1,000xg 99 
for 15 minutes at 4
o
C and supernatant removed. The pellet was re-homogenized in 600μl chilled 100 
homogenization buffer and spun at 1,000xg for 10 minutes at 4
o
C. The supernatant was combined 101 
with the supernatant from the previous step and centrifuged at 12,000xg for 30 minutes at 4
o
C to 102 
pellet the mitochondria. MtDNA was extracted using a DNA Mini Kit (Qiagen:51304). Method D 103 
was a modification of the method by Clayton and Shadel [16] and purchased as a commercial kit 104 
(Promokine:PK-CA577-K280). 100mg of brain tissue was homogenized with the reagents provided, 105 
according to the manufacturer’s instructions. In Method E 200mg of tissue was dissociated using the 106 
gentleMACS dissociator and a mitochondrial extraction kit (Miltenyi Biotech:130-097-340) according 107 
to the manufacturer’s protocol, with the exception of using an increased quantity of extraction buffer 108 
(40μl Solution 1 and 1ml 1x Solution 2). After homogenization the sample was spun at 200xg for 30 109 
seconds and passed through a 70μm pre-separation filter (Miltenyi Biotec:130-095-823) and washed 110 
with Solution 3. The homogenate was spun at 500xg for 5 minutes at 4°C and the supernatant 111 
removed. The supernatant was magnetically labelled with 100μl anti-human TOM22 antibody-112 
microbeads (Miltenyi Biotech:130-094-532) for 1 hour at 4°C under continuous agitation. The eluate 113 
was added to a LS column (Miltenyi Biotech:130-042-401) and placed in a MACS separator 114 
(Miltenyi Biotech:130-042-302) and washed. Upon removing the column from the magnetic field the 115 
mitochondria were pelleted by centrifugation at 13,000xg for 2 minutes at 4°C, washed in 1ml 116 
Storage Buffer and centrifuged at 13,000xg for 2 minutes at 4°C. The supernatant was discarded and 117 
mtDNA extracted using a DNA Mini Kit (Qiagen:51304). We compared these approaches to DNA we 118 
had previously isolated [17] using a phenol-chloroform protocol, which isolates both ncDNA and 119 
mtDNA We assessed the purity of each method using qRT-PCR as previously described (6). Briefly, 120 
the number of copies of mtDNA relative to ncDNA was determined by dividing the calculated 121 
number of copies of mtDNA (MT-CYB assay) by the calculated number of copies of ncDNA (B2M 122 
assay). 123 
Our data showed that Method B (linear DNA digestion) gave the lowest purity (1,242 mtDNA 124 
copies/ncDNA copy), and Method E (magnetic-microbeads) the highest purity (14,654 mtDNA 125 
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copies/ncDNA copy) (Figure 1A; Table 1). Of particular interest to the study was the relative 126 
enrichment compared to a standard phenol-chloroform extraction (Figure 1B). The only method to 127 
show no enrichment was Method B (linear DNA digestion). All other techniques showed a positive 128 
enrichment of mtDNA compared to phenol-chloroform. Methods A (Percoll), C (differential 129 
centrifugation) and D (rapid differential centrifugation) all gave modest positive enrichments of 2.4-, 130 
1.7- and 2.9- fold respectively. Although giving one of the lowest yields (3.2µg), the optimal method 131 
for enrichment relative to ncDNA was Method E (magnetic-microbeads), which gave a 10.7-fold 132 
enrichment, and was the only method to show significantly more copies of mtDNA/ncDNA copy 133 
compared to phenol-chloroform extraction (P=1.88x10
-3
). Using this method we saw a significant 134 
enrichment of mtDNA/ncDNA compared to Methods A (P=0.019), B (P=6.97x10
-4
) and C 135 
(P=8.48x10
-3
). To validate our enrichment, two of the biological replicates from Method E were 136 
compared to a non-enriched standard from phenol-chloroform extraction using NGS. DNA samples 137 
were fragmented by sonication using a Bioruptor (Diagenode:UCD-200) to an average size of 138 
~240bp. Sequencing libraries were prepared using the NEXTflex Rapid DNA-Seq kit (Bioo 139 
Scientific) and ligated to pre-indexed adapters (NEXTflex-96 DNA Barcodes; Bioo Scientific). 140 
Adapter-ligated DNA was amplified for 10 cycles using Herculase II Fusion DNA Polymerase 141 
(Agilent Technologies) and NEXTflex PCR primer mix, then pooled for sequencing on an Illumina 142 
HiSeq2500 (100bp paired-end, rapid run mode). Raw reads were quality and adaptor trimmed using 143 
TrimGalore! (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) before being aligned 144 
to GRCH37. Only high quality (Phred <20) reads, uniquely mapping to the genome were considered 145 
and total read counts were taken. For the non-enriched standard 1.1% of reads mapped to the 146 
mitochondrial genome, compared to an average of 18.7% (16.2% and 21.2% respectively) of reads 147 
with Method E, demonstrating an average 16.8 fold enrichment.   148 
 149 
Despite Method E providing a greater enrichment than Method C (differential centrifugation) in 150 
mouse liver [18] and a similar enrichment to Percoll in an osteosarcoma cell line [19], higher levels of 151 
mitochondrial enrichment have previously been reported [20]. However, this method, like Method B 152 
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in our study, relies on the circular nature of the intact mitochondrial genome, which, whilst present in 153 
cell lines and blood, may be more degraded in frozen, archived brain. In the context of genomic 154 
studies of mtDNA, where the exclusion of NUMTs is imperative, the relative enrichment of mtDNA is 155 
of far greater importance than the yield. Thus, although we saw a lower yield with magnetic-156 
microbeads (Method E) compared to the majority of methods tested, we observed the greatest purity 157 
with this method. The reasons for the observed greater enrichment of mtDNA/ncDNA relative to 158 
Percoll (Method A) in our study compared to the analysis by Hornig-Do and colleagues potentially 159 
may include i) our use of qRT-PCR, which is more sensitive than western blot, ii) our use of frozen 160 
samples, rather than fresh samples and iii) the use of brain, rather than a cell line, as brain has high 161 
levels of mitochondria. To our knowledge our study represents the first to systematically compare and 162 
contrast methods for isolating mtDNA from small quantities of frozen, post-mortem human brain. Our 163 
findings suggest that magnetic-microbeads provide a significant enrichment of mtDNA compared to 164 
any other method tested. This may be due to a number of reasons, for example the automated 165 
homogenization of tissue in this protocol could provide a more consistent and gentle approach than 166 
other techniques and the use of magnetically labelled antibodies provides a specific capture of intact 167 
mitochondria, which may also contain less degraded mtDNA. We recommend that given the current 168 
interest in studying the mitochondrial genome in human brain, that the magnetic-microbead method 169 
from Miltenyi Biotech is used prior to DNA extraction to minimize the inclusion of NUMTs in 170 
downstream analyses. 171 
 172 
 173 
Author Contributions 174 
M.D. J.M. and K.L. conceived the idea for the study. M.D., J.B., R.C., M.J. and A.R.J. performed the 175 
experiments. C.T. and S.A-S provided tissue from the London Neurodegenerative Disease Brain 176 
Bank. M.D. and K.L. analyzed the data and drafted the manuscript. All authors approved of the final 177 
manuscript prior to submission. 178 
8 
 
Acknowledgements 179 
This work was funded by an Alzheimer’s Research UK grant to K.L. (ARUK-PPG2013A-5). The 180 
authors would like to thank the London Neurodegenerative Disease Brain Bank and Brains for 181 
Dementia Research (BDR) and their donors for provision of tissue for the study.  182 
 183 
Competing Interests 184 
The authors declare that they have no conflicts of interest in regard to this work. 185 
 186 
References 187 
1. Fu, W., et al., Activity and metabolism-related Ca2+ and mitochondrial dynamics in co-188 
cultured human fetal cortical neurons and astrocytes. Neuroscience, 2013. 250: p. 520-35. 189 
2. Chan, S.L., et al., Mitochondrial uncoupling protein-4 regulates calcium homeostasis and 190 
sensitivity to store depletion-induced apoptosis in neural cells. J Biol Chem, 2006. 281(49): p. 191 
37391-403. 192 
3. Pradelli, L.A., M. Beneteau, and J.E. Ricci, Mitochondrial control of caspase-dependent and -193 
independent cell death. Cell Mol Life Sci, 2010. 67(10): p. 1589-97. 194 
4. Devi, L. and M. Ohno, Mitochondrial dysfunction and accumulation of the beta-secretase-195 
cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Neurobiol Dis, 196 
2012. 45(1): p. 417-24. 197 
5. Pinto, M., et al., Mitochondrial DNA damage in a mouse model of Alzheimer's disease 198 
decreases amyloid beta plaque formation. Neurobiol Aging, 2013. 34(10): p. 2399-407. 199 
6. Lunnon, K., et al., Mitochondrial dysfunction and immune activation are detectable in early 200 
Alzheimer's disease blood. J Alzheimers Dis, 2012. 30(3): p. 685-710. 201 
7. Anderson, S., et al., Sequence and organization of the human mitochondrial genome. Nature, 202 
1981. 290(5806): p. 457-65. 203 
9 
 
8. Tuppen, H.A., et al., Mitochondrial DNA mutations and human disease. Biochim Biophys 204 
Acta, 2010. 1797(2): p. 113-28. 205 
9. Elliott, H.R., et al., Pathogenic mitochondrial DNA mutations are common in the general 206 
population. Am J Hum Genet, 2008. 83(2): p. 254-60. 207 
10. Kogelnik, A.M., et al., MITOMAP: a human mitochondrial genome database. Nucleic Acids 208 
Res, 1996. 24(1): p. 177-9. 209 
11. Wallace, D.C. and D. Chalkia, Mitochondrial DNA genetics and the heteroplasmy conundrum 210 
in evolution and disease. Cold Spring Harb Perspect Biol, 2013. 5(11): p. a021220. 211 
12. Hazkani-Covo, E., R.M. Zeller, and W. Martin, Molecular Poltergeists: Mitochondrial DNA 212 
Copies (numts) in Sequenced Nuclear Genomes. Plos Genetics, 2010. 6(2). 213 
13. Bensasson, D., et al., Mitochondrial pseudogenes: evolution's misplaced witnesses. Trends in 214 
Ecology & Evolution, 2001. 16(6): p. 314-321. 215 
14. Devall, M., J. Mill, and K. Lunnon, The mitochondrial epigenome: a role in Alzheimer's 216 
disease? Epigenomics, 2014. 6(6): p. 665-75. 217 
15. Zhou, J., L. Liu, and J. Chen, Method to purify mitochondrial DNA directly from yeast total 218 
DNA. Plasmid, 2010. 64(3): p. 196-9. 219 
16. Clayton, D.A. and G.S. Shadel, Isolation of mitochondria from tissue culture cells. Cold 220 
Spring Harb Protoc, 2014. 2014(10): p. pdb prot080002. 221 
17. Lunnon, K., et al., Cross-tissue methylomic profiling in Alzheimer's disease implicates a role 222 
for cortex-specific deregulation of ANK1 in neuropathology. Nat Neurosci, 2014. Sept; 17(9): 223 
p. 1164-70. 224 
18. Franko, A., et al., Efficient isolation of pure and functional mitochondria from mouse tissues 225 
using automated tissue disruption and enrichment with anti-TOM22 magnetic beads. PLoS 226 
One, 2013. 8(12): p. e82392. 227 
19. Hornig-Do, H.T., et al., Isolation of functional pure mitochondria by superparamagnetic 228 
microbeads. Anal Biochem, 2009. 389(1): p. 1-5. 229 
20. Jayaprakash, A.D., et al., Stable heteroplasmy at the single-cell level is facilitated by 230 
intercellular exchange of mtDNA. Nucleic Acids Res, 2015. 43(4): p. 2177-87. 231 
10 
 
 232 
Table 1. An overview of starting material for each isolation technique and resulting yield.  
 
Method A B C D E F 
Overview Percoll DNAse 
digestion 
Differential 
centrifugation 
Rapid differential 
centrifugation 
Magnetic microbeads 
(anti-TOM22) 
Phenol-chloroform 
Quantity of starting Material 150mg  
(tissue) 
20μg  
(DNA) 
100mg 
(tissue) 
100mg 
(tissue) 
200mg 
(tissue) 
100mg 
(tissue) 
Number of samples 4 6 4 3 5 5 
Average concentration (ng/µl) DNA collected (±SEM) 162.4 (11.6) 40.3 (10.1) 23.7 (8.0) 257 (138.4)  32.4 (7.0) N/A 
Average yield (µg) DNA collected (±SEM) 8.1 (0.58) 2.0 (0.50) 4.7 (1.60) 13.7 (6.35) 3.2 (0.70) N/A 
Average copies of mtDNA (±SEM) 41,530 
(15,468) 
12,092,501 
(7,742,804) 
28,886,594 
(12,405,939) 
403,381 
(194,557) 
5,321,960 
(1,246,724) 
459,264  
(751,075) 
Average copies of ncDNA (±SEM) 155 (85) 8,768 (3,731) 20,746 (11,256) 720 (449) 402 (86) 4,011 (585) 
Average ratio mtDNA/ncDNA (±SEM) 3,337 (1,988) 1,242 (309) 2,270 (960) 3,949 (3,424) 14,654 (2,922) 1,367 (35) 
Fold Enrichment mtDNA/ncDNA relative to phenol-
chloroform (P-value) 
2.44 (0.297) 0.91 (0.725) 1.66 (0.320) 2.89 (0.342) 10.72 (1.88x10-3) N/A 
In brief we compared five methods of isolating mtDNA in post-mortem human brain tissue; (A) discontinuous Percoll gradient, (B) DNase digestion of linear 
DNA, (C) differential centrifugation, (D) rapid (commercial) mitochondrial isolation via differential centrifugation (E) magnetic labelling and pull-down of 
mitochondria using an antibody to TOM22. We compared the yield and enrichment to a non-enriched standard (phenol-chloroform) using an unpaired two-
tailed t-test. 
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Figure 1: Enrichment of mtDNA relative to ncDNA. In total five methods (Percoll (A), DNase digestion (B), 
differential centrifugation (C), rapid differential centrifugation (D) and magnetic microbeads (E) were compared 
to a non-enriched standard (phenol-chloroform (F)). Shown is the ratio of mtDNA/ncDNA (±SEM) (Fig 1A) and 
the relative enrichment compared to phenol-chloroform (Fig 1B). *** = P<0.005 
 
  
